BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 23224996)

  • 21. A newly identified Thr99fsX110 mutation in the PMP22 gene associated with an atypical phenotype of the hereditary neuropathy with liability to pressure palsies.
    Moszyńska I; Kabzińska D; Sinkiewicz-Darol E; Kochański A
    Acta Biochim Pol; 2009; 56(4):627-30. PubMed ID: 19830275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic basis of inherited peripheral neuropathies.
    Suter U; Patel PI
    Hum Mutat; 1994; 3(2):95-102. PubMed ID: 7515304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PMP22-Related neuropathies and other clinical manifestations in Chinese han patients with charcot-marie-tooth disease type 1.
    Zhan Y; Zi X; Hu Z; Peng Y; Wu L; Li X; Jiang M; Liu L; Xie Y; Xia K; Tang B; Zhang R
    Muscle Nerve; 2015 Jul; 52(1):69-75. PubMed ID: 25522693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for a recessive PMP22 point mutation in Charcot-Marie-Tooth disease type 1A.
    Roa BB; Garcia CA; Pentao L; Killian JM; Trask BJ; Suter U; Snipes GJ; Ortiz-Lopez R; Shooter EM; Patel PI; Lupski JR
    Nat Genet; 1993 Oct; 5(2):189-94. PubMed ID: 8252046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel homozygous variant extending the peripheral myelin protein 22 by 9 amino acids causes early-onset Charcot-Marie-Tooth disease with predominant severe sensory ataxia.
    Zambon AA; Pitt M; Laurà M; Polke JM; Reilly MM; Muntoni F
    J Peripher Nerv Syst; 2020 Sep; 25(3):303-307. PubMed ID: 32412171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noncanonical splice-site variant in peripheral myelin protein 22 gene (PMP22) in a patient with hereditary neuropathy with liability to pressure palsies.
    Kawamoto N; Hamada Y; Kobayashi S; Naruse H; Ishiura H; Matsukawa T; Mitsui J; Tsuji S; Sonoo M; Toda T
    J Peripher Nerv Syst; 2023 Sep; 28(3):513-517. PubMed ID: 37170477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stoichiometric alteration of PMP22 protein determines the phenotype of hereditary neuropathy with liability to pressure palsies.
    Li J; Ghandour K; Radovanovic D; Shy RR; Krajewski KM; Shy ME; Nicholson GA
    Arch Neurol; 2007 Jul; 64(7):974-8. PubMed ID: 17620487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and Molecular Characterization of PMP22 point mutations in Taiwanese patients with Inherited Neuropathy.
    Liao YC; Tsai PC; Lin TS; Hsiao CT; Chao NC; Lin KP; Lee YC
    Sci Rep; 2017 Nov; 7(1):15363. PubMed ID: 29127354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of compound heterozygous mice reveals that the Trembler mutation can behave as a gain-of-function allele.
    Adlkofer K; Naef R; Suter U
    J Neurosci Res; 1997 Sep; 49(6):671-80. PubMed ID: 9335255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Charcot-Marie-Tooth disease and related peripheral neuropathies.
    De Jonghe P; Timmerman V; Nelis E; Martin JJ; Van Broeckhoven C
    J Peripher Nerv Syst; 1997; 2(4):370-87. PubMed ID: 10975746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tead1 regulates the expression of Peripheral Myelin Protein 22 during Schwann cell development.
    Lopez-Anido C; Poitelon Y; Gopinath C; Moran JJ; Ma KH; Law WD; Antonellis A; Feltri ML; Svaren J
    Hum Mol Genet; 2016 Jul; 25(14):3055-3069. PubMed ID: 27288457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inherited peripheral neuropathy.
    Keller MP; Chance PF
    Semin Neurol; 1999; 19(4):353-62. PubMed ID: 10716658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variable phenotypes are associated with PMP22 missense mutations.
    Russo M; Laurá M; Polke JM; Davis MB; Blake J; Brandner S; Hughes RA; Houlden H; Bennett DL; Lunn MP; Reilly MM
    Neuromuscul Disord; 2011 Feb; 21(2):106-14. PubMed ID: 21194947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel PMP22 mutation Ser22Phe in a family with hereditary neuropathy with liability to pressure palsies and CMT1A phenotypes.
    Kleopa KA; Georgiou DM; Nicolaou P; Koutsou P; Papathanasiou E; Kyriakides T; Christodoulou K
    Neurogenetics; 2004 Sep; 5(3):171-5. PubMed ID: 15205993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
    Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
    J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 5' regulatory sequence of the PMP22 in the patients with Charcot-Marie-Tooth disease.
    Sinkiewicz-Darol E; Kabzińska D; Moszyńska I; Kochański A
    Acta Biochim Pol; 2010; 57(3):373-7. PubMed ID: 20842290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetraspan myelin protein PMP22 and demyelinating peripheral neuropathies: new facts and hypotheses.
    Müller HW
    Glia; 2000 Jan; 29(2):182-5. PubMed ID: 10625337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for Charcot-Marie-Tooth type 1A and hereditary neuropathy with liability to pressure palsy in archival nerve biopsy samples by direct-double-differential PCR.
    Beckmann A; Schröder JM
    Acta Neuropathol; 2000 Nov; 100(5):459-63. PubMed ID: 11045666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for mutations in the peripheral myelin genes PMP22, MPZ and Cx32 (GJB1) in Russian Charcot-Marie-Tooth neuropathy patients.
    Mersiyanova IV; Ismailov SM; Polyakov AV; Dadali EL; Fedotov VP; Nelis E; Löfgren A; Timmerman V; van Broeckhoven C; Evgrafov OV
    Hum Mutat; 2000; 15(4):340-7. PubMed ID: 10737979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice.
    Adlkofer K; Martini R; Aguzzi A; Zielasek J; Toyka KV; Suter U
    Nat Genet; 1995 Nov; 11(3):274-80. PubMed ID: 7581450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.